首页 | 本学科首页   官方微博 | 高级检索  
检索        

HPLC法测定中成药中9种化学降糖药的研究
引用本文:那顺朝克图,侯扬,尤立华,叶萌,刘亚琴,赵秀梅,杨秉呼.HPLC法测定中成药中9种化学降糖药的研究[J].中国药师,2010,13(4):465-467.
作者姓名:那顺朝克图  侯扬  尤立华  叶萌  刘亚琴  赵秀梅  杨秉呼
作者单位:北京市东城区药品检验所,北京,100027
基金项目:北京科委基金,北京东城区科委基金 
摘    要:目的:建立测定添加在降糖中成药中的格列吡嗪、格列本脲、格列齐特、格列喹酮、格列美脲、盐酸吡格列酮、盐酸罗格列酮、那格列奈、瑞格列奈共9种化学降糖药的高效液相分析方法。方法:色谱柱:ThermoC18(150mm×4.6mm,5μm),流动相:醋酸盐缓冲溶液(10mmol·L-1醋酸铵和20mmol·L-1三乙胺,醋酸调pH至5.5)-乙腈(61:39),流速:1ml·min-1,检测波长:210nm,柱温:30℃,进样20山。结果:9种化学降糖药完全分离,检出限为4~18ng;9种药物具有宽的线性范围和良好的线性关系(r≥0.9994);日内、日问RSD分别为O.09%~1.42%和O.30%~1.88%;在中药中的加样回收率除个别药物低浓度外均大于80%,RSD为0.26%-5.91%。结论:该方法用于检测中成药中的化学降糖药快速、简便、高效。

关 键 词:格列吡嗪  格列本脲  格列齐特  格列喹酮  格列美脲  盐酸吡格列酮  盐酸罗格列酮  那格列奈  瑞格列奈  高效  液相色谱  降糖中成药

Simultaneous Determination of Nine Anti-diabetic Drugs in Chinese Traditional Patent Medidnes by HPLC
Nashunchaoketu,Hou Yang,You Lihua,Ye Meng,Liu Yaqin,Zhao Xiumei,Yang Binghu.Simultaneous Determination of Nine Anti-diabetic Drugs in Chinese Traditional Patent Medidnes by HPLC[J].China Pharmacist,2010,13(4):465-467.
Authors:Nashunchaoketu  Hou Yang  You Lihua  Ye Meng  Liu Yaqin  Zhao Xiumei  Yang Binghu
Institution:(Beijing Dongcheng Institute for Drug Con- trol, Beijing 100027, China)
Abstract:Objective: To establish the HPLC method for the simultaneous determination of nine anti-diabetic agents in chinese traditional patent medicines. The chemical anti-diabetic agents were glipizide, glibenclamide, gliclazide, gliquizone, glimepiride, piolita- zone hydrochloride, rosiglitazone hydrochloride, nateglinide, repaglinide. Method: The Thermo Cls analytical column ( 150 mm x 4.6 mm,5txm) was used,the mobile phase was acetonitrile-acetate buffer( 10 mmol-L-1 ammonium acetate and 20 mmol. L-ltriethyl- amine, the pH of solution was adjusted to 5.5 using acetic acid) (61: 39), the temperature was 30 ~C. Result: The lowest detectable limits were 4-18 ng, the linear relation and range of each component was obtained, and correlation coetticients were better within their ranges (r~〉0. 999 4). Intra-day and inter-day relative standard deviations(RDSs) were 0. 09%-1.42% and 0. 30%-1.88% respec- tively. The average recoveries in different kinds of chinese traditional patent medicine were more than 80% except for the low concentra- tion of glimepiride was 46.5% ,RSDs of recoveries were 0. 26% -5.91%. Conclusion: The study reveals the method can be used in analysis of anti-diabetic drugs in chinese traditional patent medicine, and it is rapid, convenient, economic specific and accurate.
Keywords:Glipizide  Glibenclamide  Gliclazide  Gliquizone  Glimepiride  Piolitazone hydrochloride  Rosiglitazone hydrochlo- ride  Nateglinide  Repaglinide  HPLC  Anti-diabetic chinese traditional patent medicine
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号